|
Volumn 6, Issue 9, 1997, Pages 1227-1245
|
Novelties in the field of fluoroquinolones
|
Author keywords
BAY 12 8039; Fluoroquinolones; HSR 903; LB 20304
|
Indexed keywords
1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE;
5 AMINO 7 (7 AMINO 5 AZASPIRO[2.4]HEPT 5 YL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 8 METHYL 4 OXO 3 QUINOLINECARBOXYLIC ACID;
7 (3 AMINOMETHYL 3 FLUOROMETHYL 1 PYRROLIDINYL) 1 CYCLOPORPYL 6 FLUORO 1,4 DIHYDRO 8 METHOXY 4 OXO 3 QUINOLINECARBOXYLIC ACID;
7 (3 AMINOMETHYL 3 FLUOROMETHYL 1 PYRROLIDINYL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 8 METHOXY 4 OXO 3 QUINOLINECARBOXYLIC ACID;
BALOFLOXACIN;
CETEFLOXACIN;
CIPROFLOXACIN;
CLINAFLOXACIN;
E 4534;
FA 103;
FANDOFLOXACIN;
FD 501;
GATIFLOXACIN;
GEMIFLOXACIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
MF 5137;
MOXIFLOXACIN;
OFLOXACIN;
OPC 17611;
PRULIFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
S 32730;
SPARFLOXACIN;
TEMAFLOXACIN;
TOSUFLOXACIN;
TROVAFLOXACIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WQ 0835;
WQ 2756;
WQ 2765;
DRUG DEVELOPMENT;
HUMAN;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
REVIEW;
STREPTOCOCCUS PNEUMONIAE;
|
EID: 0030882529
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.6.9.1227 Document Type: Review |
Times cited : (19)
|
References (58)
|